Citations

Showing 10 of 108094 citations.

Use of heparin to rescue immunosuppressive monocyte reprogramming by glioblastoma-derived extracellular vesicles
Fain, Cori E. , Tritz, Zachariah P. , Jin‐Lee, Helen J. , Geiger, Philipp , Peterson, Timothy E., Himes, Benjamin , Nesvick, Cody L. , Jung, Mi-Yeon, Parney, Ian F.

Mayo Clinic

Journal of Neurosurgery | September 16, 2022 | Volume: 138 | Issue: 5 | Pages: 1291-1301

10.3171/2022.6.jns2274 | PMID 36115048 Get It

OBJECTIVE The profound immunosuppression found in glioblastoma (GBM) patients is a critical barrier to effective immunotherapy. Multiple mechanisms of tumor-mediated immune suppression exist, and the induction of immunosuppressive monocytes such as myeloid-derived suppressor cells (MDSCs) is increasingly appreciated as a key part of this pathology. GBM-derived extracellular vesicles (EVs) can induce the formation of MDSCs. The authors sought to identify the molecular consequences of these interactions in myeloid cells in order to identify potential targets that could pharmacologically disrupt GBM EV–monocyte interaction as a means to ameliorate tumor-mediated immune suppression. Heparin-sulfate proteoglycans (HSPGs) are a general mechanism by which EVs come into association with their target cells, and soluble heparin has been shown to interfere with EV-HSPG interactions. The authors sought to assess the efficacy of heparin treatment for mitigating the effects of GBM EVs on the formation of MDSCs. METHODS GBM EVs were collected from patient-derived cell line cultures via staged ultracentrifugation and cocultured with monocytes collected from apheresis cones from healthy blood donors. RNA was isolated from EV-conditioned and unconditioned monocytes after 72 hours of coculture, and RNA-sequencing analysis performed. For the heparin treatment studies, soluble heparin was added at the time of EV-monocyte coculture and flow cytometry analysis was performed 72 hours later. After the initial EV-monocyte coculture period, donor-matched T-cell coculture studies were performed by adding fluorescently labeled and stimulated T cells for 5 days of coculture. RESULTS Transcriptomic analysis of GBM EV–treated monocytes demonstrated downregulation of several important immunological and metabolic pathways, with upregulation of the pathways associated with synthesis of cholesterol and HSPG. Heparin treatment inhibited association between GBM EVs and monocytes in a dose-dependent fashion, which resulted in a concomitant reduction in MDSC formation (p < 0.01). The authors further demonstrated that reduced MDSC formation resulted in a partial rescue of immune suppression, as measured by effects on activated donor-matched T cells (p < 0.05). CONCLUSIONS The authors demonstrated that GBM EVs induce broad but reproducible reprogramming in monocytes, with enrichment of pathways that may portend an immunosuppressive phenotype. The authors further demonstrated that GBM EV–monocyte interactions are potentially druggable targets for overcoming tumor-mediated immune suppression, with heparin inhibition of EV-monocyte interactions demonstrating proof of principle.
High Soluble Amyloid-β42 Predicts Normal Cognition in Amyloid-Positive Individuals with Alzheimer’s Disease-Causing Mutations
(DIAN), the Dominantly Inherited Alzheimer Consortia, Cilia, Roberto , Sharma, Jennifer , Schneider, Lon S. , Graff‐Radford, Neill R. , Mori, Hiroshi , Nübling, Georg, Andaloussi, Samir EL , Svenningsson, Per , Vöglein, Jonathan , Vöglein, Jonathan , Svenningsson, Per , Sturchio, Andrea , (DIAN), the Dominantly Inherited Alzheimer Consortia, Dwivedi, Alok , Malm, Tarja , Wood, Matthew J. A. , Hill, Emily J. , Nübling, Georg , Ezzat, Kariem , Espay, Alberto J.

Mayo Clinic

Journal of Alzheimer's Disease | September 16, 2022 | Volume: 90 | Issue: 1 | Pages: 333-348

10.3233/jad-220808 | PMID 36120786 Get It

Background: In amyloid-positive individuals at risk for Alzheimer’s disease (AD), high soluble 42-amino acid amyloid-β (Aβ42) levels are associated with normal cognition. It is unknown if this relationship applies longitudinally in a genetic cohort. Objective: To test the hypothesis that high Aβ42 preserves normal cognition in amyloid-positive individuals with Alzheimer’s disease (AD)-causing mutations (APP, PSEN1, or PSEN2) to a greater extent than lower levels of brain amyloid, cerebrospinal fluid (CSF) phosphorylated tau (p-tau), or total tau (t-tau). Methods: Cognitive progression was defined as any increase in Clinical Dementia Rating (CDR = 0, normal cognition; 0.5, very mild dementia; 1, mild dementia) over 3 years. Amyloid-positivity was defined as a standard uptake value ratio (SUVR) ≥1.42 by Pittsburgh compound-B positron emission tomography (PiB-PET). We used modified Poisson regression models to estimate relative risk (RR), adjusted for age at onset, sex, education, APOE4 status, and duration of follow-up. The results were confirmed with multiple sensitivity analyses, including Cox regression. Results: Of 232 mutation carriers, 108 were PiB-PET-positive at baseline, with 43 (39.8%) meeting criteria for progression after 3.3±2.0 years. Soluble Aβ42 levels were higher among CDR non-progressors than CDR progressors. Higher Aβ42 predicted a lower risk of progression (adjusted RR, 0.36; 95% confidence interval [CI], 0.19–0.67; p = 0.002) better than lower SUVR (RR, 0.81; 95% CI, 0.68–0.96; p = 0.018). CSF Aβ42 levels predicting lower risk of progression increased with higher SUVR levels. Conclusion: High CSF Aβ42 levels predict normal cognition in amyloid-positive individuals with AD-causing genetic mutations.
Bevacizumab-induced Coagulative Necrosis with Restricted Diffusion
Agarwal, Amit , Desai, Amit , Vibhute, Prasanna , Desai, Amit , Agarwal, Amit Kumar , Gupta, Vivek

Mayo Clinic

Radiology: Imaging Cancer | September 16, 2022 | Volume: 4 | Issue: 5 | Pages: No page available

10.1148/rycan.220089 | PMID 36112037 Get It

Oncology: Emerging Therapeutic Approaches
Harris, Adrian, Zaromytidou, Alexia-Ileana, Dong, Haidong , Medema, Jan Paul , Wu, Yi-Long Lung Cancer

Mayo Clinic

No container title available | September 16, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.52843/cassyni.4mw582 Get It

This webinar is the first of a new series that brings together international experts to discuss ongoing developments in cancer research. This webinar focusses on emerging therapeutics, with speakers covering areas including immunotherapy, metabolic targets, and the treatment of lung and colorectal cancers. Our panellists discuss these developments, their ongoing challenges, and their global perspectives.
Dignity Conserving Therapy: An Intervention for Addressing Psychosocial and Existential Distress in Patients with Serious Illness
Weng, Jessica , Pachman, Deirdre R. , Wild, Ellen, Ingram, Cory , Ingram, Cory J, Weng, Jessica

Mayo Clinic

Palliative Medicine Reports | September 16, 2022 | Volume: 3 | Issue: 1 | Pages: No page available

10.1089/pmr.2022.0016 | PMID 36203715 Get It

Patients with serious illnesses may experience existential and psychosocial distress contributing to their pain and suffering. Addressing existential distress is challenging and may require a multidisciplinary approach. Often, providers feel uncomfortable or ill equipped to care for patients suffering from this distress. In the sample case, the patient has a life-limiting disease and is concerned about his family forgetting him, experiencing loss of dignity and narrative foreclosure. Loss of dignity is sensing hopelessness and worthlessness and a loss of self-determination. Narrative foreclosure is the premature conviction that one's life story has effectively ended. Beneficial interventions include meaning-centered psychotherapy and dignity therapy (DT). Both have an underlying theme of attempting to reverse the narrative foreclosure for patients with serious illnesses and maintain a sense of meaning in life. In addition, patients can be referred to palliative care to enhance coping and decrease depressive symptoms. Dr. Harvey Chochinov has outlined a framework that clinicians can use to care for their patients in a compassionate manner to specifically combat meaninglessness. In DT, a generativity document is created for the patient and their loved ones as part of the treatment along with the opportunity to answer the dignity conserving question. Success of this route of intervention includes greater will to live, reductions in stress, and benefits perceived by family. This article aims to give a framework to treat patients with serious illnesses experiencing psychosocial and/or existential distress.
Whole-exome Sequencing of Nigerian Prostate Tumors from the Prostate Cancer Transatlantic Consortium (CaPTC) Reveals DNA Repair Genes Associated with African Ancestry
White, Jason , Kaninjing, Ernest , Adeniji, Kayode , Jibrin, Paul, Obafunwa, John , Ogo, Chidiebere, Faruk, Mohammed , Popoola, Ademola , Fatiregun, Omolara , Oluwole, Olabode P., Karanam, Balasubramanyam , Polak, Paz , Brignole, Kathryn R. , Dean‐Colomb, Windy, Odedina, Folake T., Martin, Damali N. , Yates, Clayton , White, Jason A , Kaninjing, Ernest T , Obafunwa, John O , Mohammed, Faruk , Elhussin, Isra , Ambs, Stefan , Tang, Wei , Davis, Melissa , Campbell, Moray J , Brignole, Kathryn R , Odedina, Folakemi , Yates, Clayton , Popoola, Ademola A , Fatiregun, Omolara , Campbell, Moray J. , Rotimi, Solomon O.

Mayo Clinic

Cancer Research Communications | September 16, 2022 | Volume: 2 | Issue: 9 | Pages: 1005-1016

10.1158/2767-9764.crc-22-0136 | PMID 36922933 Get It

In this study, we used whole-exome sequencing of a cohort of 45 advanced-stage, treatment-naïve Nigerian (NG) primary prostate cancer tumors and 11 unmatched nontumor tissues to compare genomic mutations with African American (AA) and European American (EA) The Cancer Genome Atlas (TCGA) prostate cancer. NG samples were collected from six sites in central and southwest Nigeria. After whole-exome sequencing, samples were processed using GATK best practices. BRCA1 (100%), BARD1 (45%), BRCA2 (27%), and PMS2(18%) had germline alterations in at least two NG nontumor samples. Across 111 germline variants, the AA cohort reflected a pattern [BRCA1 (68%), BARD1 (34%), BRCA2 (28%), and PMS2 (16%)] similar to NG samples. Of the most frequently mutated genes, BRCA1 showed a statistically (P ≤ 0.05) higher germline mutation frequency in men of African ancestry (MAA) and increasing variant frequency with increased African ancestry. Disaggregating gene-level mutation frequencies by variants revealed both ancestry-linked and NG-specific germline variant patterns. Driven by rs799917 (T&gt;C), BRCA1 showed an increasing mutation frequency as African ancestry increased. BRCA2_rs11571831 was present only in MAA, and BRCA2_rs766173 was elevated in NG men. A total of 133 somatic variants were present in 26 prostate cancer–associated genes within the NG tumor cohort. BRCA2 (27%), APC (20%), ATM (20%), BRCA1 (13%), DNAJC6 (13%), EGFR (13%), MAD1L1 (13%), MLH1 (11%), and PMS2 (11%) showed mutation frequencies &gt;10%. Compared with TCGA cohorts, NG tumors showed statistically significant elevated frequencies of BRCA2, APC, and BRCA1. The NG cohort variant pattern shared similarities (cosign similarities ≥0.734) with Catalogue of Somatic Mutations in Cancer signatures 5 and 6, and mutated genes showed significant (q &lt; 0.001) gene ontology (GO) and functional enrichment in mismatch repair and non-homologous repair deficiency pathways. Here, we showed that mutations in DNA damage response genes were higher in NG prostate cancer samples and that a portion of those mutations correlate with African ancestry. Moreover, we identified variants of unknown significance that may contribute to population-specific routes of tumorigenesis and treatment. These results present the most comprehensive characterization of the NG prostate cancer exome to date and highlight the need to increase diversity of study populations. Significance: MAA have higher rates of prostate cancer incidence and mortality, however, are severely underrepresented in genomic studies. This is the first study utilizing whole-exome sequencing in NG men to identify West African ancestry-linked variant patterns that impact DNA damage repair pathways.
Optimizing dacryocystorhinostomy success in a “low‐dacryocystorhinostomy volume” rhinology practice
Luong, Hanna N. , Brar, Tripti , Miglani, Amar , Lal, Devyani , Lal, Devyani

Mayo Clinic

International Forum of Allergy & Rhinology | September 16, 2022 | Volume: 13 | Issue: 3 | Pages: 288-290

10.1002/alr.23084 | PMID 36111593 Get It

Outcomes of “Anterior Versus Posterior Divisional Branches of the Hypogastric Artery as Distal Landing Zone for Iliac Branch Devices”: The International Multicentric R3OYAL Registry
Lima, Guilherme Baumgardt Barbosa , Dias, Nuno , Parlani, Giambattista, Tsilimparis, Nikolaos , Timaran, Carlos H. , Kölbel, Tilo , Gargiulo, Mauro , Mani, Kevin , Tenorio, Emanuel R. , Bertoglio, Luca , Karelis, Angelos , Simonte, Gioele , D'Oria, Mario , Dias, Nuno , DeMartino, Randall, Kolbel, Tilo , Tenorio, Emanuel R , Lima, Guilherme B , D’Oria, Mario , Farber, Mark , DeMartino, Randall R. , Milner, Ross , Melissano, Germano , Maldonado, Thomas S. , Oderich, Gustavo S.

Mayo Clinic

Journal of Endovascular Therapy | September 16, 2022 | Volume: 31 | Issue: 2 | Pages: 282-294

10.1177/15266028221120513 | PMID 36113081 Get It

Objective: The aim of this multicentric registry was to assess the outcomes of “anteRior versus posteRior divisional bRanches Of the hYpogastric artery as distAl landing zone for iLiac branch devices (R3OYAL).” Methods: The main exposure of interest for the purpose of this study was the internal iliac artery (IIA) divisional branch (anterior vs posterior) that was used as distal landing zone. Early endpoints included technical success and adverse events. Late endpoints included survival, primary/secondary IIA patency, and IIA branch instability. Results: A total of 171 patients were included in the study, of which 50 received bilateral implantation of iliac branch devices (IBDs). This resulted in a total of 221 incorporated IIAs included in the final analysis, of which 40 were anterior divisional branches and 181 were posterior divisional branches. Technical success was high in both groups (anterior division: 98% vs posterior division: 100%, P = .18). Occurrence of any adverse event was noted in 14% of patients in both groups ( P = 1.0). The overall rate of freedom from the composite IBD branch instability did not show significant differences between patients receiving distal landing in the anterior or posterior division of the IIA at 3 years (79% vs 87%, log-rank test = .215). The 3-year estimates of IBD patency were significantly lower in patients who received distal landing in the anterior divisional branch than those who received distal landing in the posterior divisional branch (primary patency: 81% vs 96%, log-rank test = .009; secondary patency: 81% vs 97%, log-rank test < .001). Conclusions: The use of the anterior or posterior divisional branches of the IIA as distal landing zone for IBD implantation shows comparable profiles in terms of immediate technical success, perioperative safety, and side-branch instability up to 3 years. However, IBD patency at 3 years was higher when the distal landing zone was achieved within the posterior divisional branch of the IIA. Clinical Impact The results from this large multicentric registry confirm that use of the anterior or posterior divisional branches of the internal iliac artery (IIA) as distal landing zone for implantation of iliac branch devices (IBD) shows comparable profiles of safety and feasibility, thereby allowing to extend the indications for endovascular repair of aorto-iliac aneurysms to cases with unsuitable anatomy within the IIA main trunk. Although mid-term rates of device durability and branch instability seem to be similar, the rates of primary and secondary IBD patency at three years was favored when the distal landing zone was achieved in the posterior divisional branch of the IIA.
Advances in Stroke: Genetics, Genomics, Precision Medicine
Dichgans, Martin , Dichgans, Martin , Meschia, James F.

Mayo Clinic

Stroke | September 16, 2022 | Volume: 53 | Issue: 10 | Pages: 3211-3213

10.1161/strokeaha.122.039305 | PMID 36111545 Get It

Concrete proof of Murphy’s law: a case report of intracardiac cement embolization
Krithika, Ramaprabhu , Geske, Jeffrey B. , Villarraga, Hector R. , Geske, Jeffrey B , Crestanello, Juan A.

Mayo Clinic

European Heart Journal - Case Reports | September 16, 2022 | Volume: 6 | Issue: 10 | Pages: No page available

10.1093/ehjcr/ytac386 | PMID 36225804 Get It

Abstract Background The literature describing the complications following kyphoplasty is limited. This case report is a reminder that novel therapeutic strategies can be associated with unexpected complications. Case summary A 61-year-old woman with rheumatoid arthritis and degenerative lumbar disc disease underwent open posterior instrumented fusion with bilateral open L2 vertebroplasty elsewhere. A month after discharge, she presented to our institution with acute chest pain and dyspnoea. A subsequent gated cardiac computed tomography (CT) angiogram showed three distinct cardiopulmonary emboli. One of the cement fragments had perforated the inferior wall of the right ventricle close to the base of the posterior tricuspid valve leaflet with a moderate circumferential pericardial effusion. Operative extraction of multiple cement emboli as well as repair of the tricuspid valve was pursued. Postoperative echocardiogram showed trivial tricuspid regurgitation after repair. The patient had an uneventful postoperative course and was discharged from the hospital on postoperative Day 5. Discussion Cement embolization following kyphoplasty can be associated with serious complications such as vascular injury, hypoxaemia, pulmonary artery obstruction, and cardiac perforation. Clinicians must maintain a high index of suspicion as cement embolism may not always present acutely.